These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
571 related articles for article (PubMed ID: 7621989)
21. Lipotoxicity in human pancreatic islets and the protective effect of metformin. Lupi R; Del Guerra S; Fierabracci V; Marselli L; Novelli M; Patanè G; Boggi U; Mosca F; Piro S; Del Prato S; Marchetti P Diabetes; 2002 Feb; 51 Suppl 1():S134-7. PubMed ID: 11815472 [TBL] [Abstract][Full Text] [Related]
22. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Boden G Diabetes; 1997 Jan; 46(1):3-10. PubMed ID: 8971073 [TBL] [Abstract][Full Text] [Related]
23. Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research. Polonsky KS Diabetes; 1995 Jun; 44(6):705-17. PubMed ID: 7789637 [TBL] [Abstract][Full Text] [Related]
24. Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Koyama K; Chen G; Lee Y; Unger RH Am J Physiol; 1997 Oct; 273(4):E708-13. PubMed ID: 9357799 [TBL] [Abstract][Full Text] [Related]
25. The pathogenesis of NIDDM: the role of the pancreatic beta cell. Zawalich WS; Kelley GG Diabetologia; 1995 Aug; 38(8):986-91. PubMed ID: 7589887 [No Abstract] [Full Text] [Related]
26. Islet beta cell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fatty rat: severe dysfunction with altered glycerolipid metabolism without steatosis or a falling beta cell mass. Delghingaro-Augusto V; Nolan CJ; Gupta D; Jetton TL; Latour MG; Peshavaria M; Madiraju SR; Joly E; Peyot ML; Prentki M; Leahy J Diabetologia; 2009 Jun; 52(6):1122-32. PubMed ID: 19294363 [TBL] [Abstract][Full Text] [Related]
27. Pleiotropic effects of fatty acids on pancreatic beta-cells. Haber EP; Ximenes HM; Procópio J; Carvalho CR; Curi R; Carpinelli AR J Cell Physiol; 2003 Jan; 194(1):1-12. PubMed ID: 12447984 [TBL] [Abstract][Full Text] [Related]
28. The CB1 antagonist rimonabant decreases insulin hypersecretion in rat pancreatic islets. Getty-Kaushik L; Richard AM; Deeney JT; Krawczyk S; Shirihai O; Corkey BE Obesity (Silver Spring); 2009 Oct; 17(10):1856-60. PubMed ID: 19644453 [TBL] [Abstract][Full Text] [Related]
29. Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence. Ohneda M; Inman LR; Unger RH Diabetologia; 1995 Feb; 38(2):173-9. PubMed ID: 7713311 [TBL] [Abstract][Full Text] [Related]
30. Modulation of adipoinsular axis in prediabetic zucker diabetic fatty rats by diazoxide. Alemzadeh R; Tushaus KM Endocrinology; 2004 Dec; 145(12):5476-84. PubMed ID: 15319354 [TBL] [Abstract][Full Text] [Related]
31. GLUT2 expression and function in beta-cells of GK rats with NIDDM. Dissociation between reductions in glucose transport and glucose-stimulated insulin secretion. Ohneda M; Johnson JH; Inman LR; Chen L; Suzuki K; Goto Y; Alam T; Ravazzola M; Orci L; Unger RH Diabetes; 1993 Jul; 42(7):1065-72. PubMed ID: 8513973 [TBL] [Abstract][Full Text] [Related]
33. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032 [TBL] [Abstract][Full Text] [Related]
34. Selective modification of pyruvate dehydrogenase kinase isoform expression in rat pancreatic islets elicited by starvation and activation of peroxisome proliferator-activated receptor-alpha: implications for glucose-stimulated insulin secretion. Sugden MC; Bulmer K; Augustine D; Holness MJ Diabetes; 2001 Dec; 50(12):2729-36. PubMed ID: 11723055 [TBL] [Abstract][Full Text] [Related]
36. Augmentation of Ca2+-stimulated insulin release by glucose and long-chain fatty acids in rat pancreatic islets: free fatty acids mimic ATP-sensitive K+ channel-independent insulinotropic action of glucose. Komatsu M; Yajima H; Yamada S; Kaneko T; Sato Y; Yamauchi K; Hashizume K; Aizawa T Diabetes; 1999 Aug; 48(8):1543-9. PubMed ID: 10426371 [TBL] [Abstract][Full Text] [Related]
37. The NSY mouse: a new animal model of spontaneous NIDDM with moderate obesity. Ueda H; Ikegami H; Yamato E; Fu J; Fukuda M; Shen G; Kawaguchi Y; Takekawa K; Fujioka Y; Fujisawa T Diabetologia; 1995 May; 38(5):503-8. PubMed ID: 7489831 [TBL] [Abstract][Full Text] [Related]
38. Non-esterified fatty acids are deleterious for human pancreatic islet function at physiological glucose concentration. Dubois M; Kerr-Conte J; Gmyr V; Bouckenooghe T; Muharram G; D'Herbomez M; Martin-Ponthieu A; Vantyghem MC; Vandewalle B; Pattou F Diabetologia; 2004 Mar; 47(3):463-469. PubMed ID: 14968298 [TBL] [Abstract][Full Text] [Related]
39. A low protein diet lowers islet insulin secretion but does not alter hyperinsulinemia in obese Zucker (fa/fa) rats. Tse EO; Gregoire FM; Magrum LJ; Johnson PR; Stern JS J Nutr; 1995 Jul; 125(7):1923-9. PubMed ID: 7616309 [TBL] [Abstract][Full Text] [Related]
40. Genetically obese rats with (SHR/N-cp) and without diabetes (LA/N-cp) share abnormal islet responses to glucose. Timmers KI; Voyles NR; Recant L Metabolism; 1992 Oct; 41(10):1125-33. PubMed ID: 1406299 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]